Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-16

Clinical Trial Update: Comparison Between Biodentine and Calcium Hydroxide in the Indirect Pulp Treatment on Primary Teeth [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing Biodentine with calcium hydroxide for indirect pulp treatment in primary teeth, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biodentine (tricalcium silicate cement)
  • Calcium hydroxide (calcium hydroxide)

Snippet

Sponsor: José Arturo Garrocho Rangel | Conditions: Dental Caries | Phase 2, Phase 3 | Status: UNKNOWN